Yuji Tamagawa
Overview
Explore the profile of Yuji Tamagawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
189
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sumi S, Ishimura N, Mikami H, Okimoto E, Tamagawa Y, Mishiro T, et al.
J Neurogastroenterol Motil
. 2021 Jul;
27(3):370-376.
PMID: 34210902
Background/aims: The gastric acid pocket has an important role in gastroesophageal reflux disease development. In this study, we utilized a novel 8-channel pH monitoring system with sensor intervals of 1...
2.
Kotani S, Fukuba N, Kawashima K, Mishima Y, Sonoyama H, Okimoto E, et al.
Scand J Gastroenterol
. 2020 May;
55(5):560-564.
PMID: 32412797
Quiescent ulcerative colitis (UC) patients often have irritable bowel syndrome (IBS)-like symptoms and we recently showed that the prevalence of IBS-like symptoms in UC patients in clinical remission was significantly...
3.
Shibagaki K, Ishimura N, Yuki T, Taniguchi H, Aimi M, Kobayashi K, et al.
Endosc Int Open
. 2020 Apr;
8(4):E488-E497.
PMID: 32258370
Magnification endoscopy with narrow-band imaging (NBIME) and NBIME with acetic acid enhancement (A-NBIME) enable visualization of the vascular and microstructural patterns of colorectal polyp. We compared the diagnostic accuracy and...
4.
Shibagaki K, Yuki T, Taniguchi H, Aimi M, Miyaoka Y, Yuki M, et al.
Dig Endosc
. 2019 Jul;
32(3):355-363.
PMID: 31361925
Background And Aim: The esophageal triamcinolone acetonide (TA)-filling method is a novel local approach for stenosis prevention after extensive esophageal endoscopic submucosal dissection (ESD). We evaluated this method after subcircumferential...
5.
Ishimura N, Sumi S, Okada M, Mikami H, Okimoto E, Nagano N, et al.
Clin Gastroenterol Hepatol
. 2018 Aug;
17(7):1405-1407.
PMID: 30144524
Eosinophilic esophagitis (EoE) is an allergic inflammatory disorder that is characterized clinically by symptoms related to esophageal dysfunction and histologically by eosinophil-predominant inflammation. Its prevalence has been increasing rapidly in...
6.
Ishimura N, Sumi S, Okada M, Izumi D, Mikami H, Okimoto E, et al.
Endosc Int Open
. 2018 Feb;
6(2):E165-E172.
PMID: 29399613
Background And Study Aims: Characteristic endoscopic findings, such as linear furrows, rings, and whitish exudates, indicate the presence of esophageal eosinophilia (EE), though no specific findings are known to distinguish...
7.
Shibagaki K, Ishimura N, Oshima N, Mishiro T, Fukuba N, Tamagawa Y, et al.
Gastrointest Endosc
. 2017 Aug;
87(2):380-389.
PMID: 28843584
Background And Aims: Endoscopic submucosal dissection (ESD) for extensive esophageal carcinomas may cause severe stenosis requiring endoscopic balloon dilations (EBDs). A standard prevention method has not been established. We propose...
8.
Tamagawa Y, Ishimura N, Uno G, Aimi M, Oshima N, Yuki T, et al.
Lab Invest
. 2015 Nov;
96(3):325-37.
PMID: 26568294
Crosstalk between the Notch signaling pathway and Caudal-related homeobox 2 (Cdx2) has important roles in the development of Barrett's esophagus (BE). We investigated the expression and function of the Notch...
9.
Shimura S, Ishimura N, Mikami H, Okimoto E, Uno G, Tamagawa Y, et al.
J Neurogastroenterol Motil
. 2015 Nov;
22(1):60-8.
PMID: 26554916
Background/aims: Small intestinal bacterial overgrowth (SIBO) is considered to be involved in the pathogenesis of functional gastrointestinal disorders (FGID). However, the prevalence and clinical conditions of SIBO in patients with...
10.
Tamagawa Y, Miyake T, Mishiro T, Ohara S, Furuta K, Kazumori H, et al.
Clin J Gastroenterol
. 2015 Jul;
4(4):202-206.
PMID: 26189520
Eosinophilic esophagitis is a rare chronic disease that mainly occurs in middle-aged males. Treatment with a glucocorticoid and/or proton pump inhibitor is usually necessary to relieve unpleasant symptoms. An 83-year-old...